1070 5/500 (Xigduo XR 5 mg / 500 mg)
Generic Name: dapagliflozin/metformin
Pill with imprint 1070 5/500 is Orange, Capsule-shape and has been identified as Xigduo XR 5 mg / 500 mg. It is supplied by AstraZeneca Pharmaceuticals.
Xigduo XR is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Xigduo XR 5 mg / 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 1070 5/500
Xigduo XR
- Generic Name
- dapagliflozin/metformin
- Imprint
- 1070 5/500
- Strength
- 5 mg / 500 mg
- Color
- Orange
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AstraZeneca Pharmaceuticals
- National Drug Code (NDC)
- 00310-6250
- Inactive Ingredients
-
microcrystalline cellulose,
lactose anhydrous,
silicon dioxide,
magnesium stearate,
hypromellose 2208 (100000 mPa.s),
hypromellose 2910 (5 mPa.s)
Note: Inactive ingredients may vary.
More about Xigduo XR (dapagliflozin / metformin)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (15)
- Drug images
- Pricing & coupons
- En español
- Drug class: antidiabetic combinations
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.